322 related articles for article (PubMed ID: 25294311)
1. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors.
Ma Y; Liang S; Guo J; Guo R; Wang H
J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311
[TBL] [Abstract][Full Text] [Related]
2. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
3. Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe.
Wu H; Chen H; Pan D; Ma Y; Liang S; Wan Y; Fang Y
Mol Imaging Biol; 2014 Dec; 16(6):781-92. PubMed ID: 25001194
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
5. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
[TBL] [Abstract][Full Text] [Related]
6. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
[TBL] [Abstract][Full Text] [Related]
7. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
8. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
9. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
Cai W; Chen K; Li ZB; Gambhir SS; Chen X
J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
[TBL] [Abstract][Full Text] [Related]
10. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
11. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
12. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
Durkan K; Jiang Z; Rold TL; Sieckman GL; Hoffman TJ; Bandari RP; Szczodroski AF; Liu L; Miao Y; Reynolds TS; Smith CJ
Nucl Med Biol; 2014 Feb; 41(2):133-9. PubMed ID: 24480266
[TBL] [Abstract][Full Text] [Related]
13. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.
Liu Z; Niu G; Wang F; Chen X
Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404
[TBL] [Abstract][Full Text] [Related]
14. A radiofluorinated divalent cystine knot peptide for tumor PET imaging.
Jiang L; Kimura RH; Ma X; Tu Y; Miao Z; Shen B; Chin FT; Shi H; Gambhir SS; Cheng Z
Mol Pharm; 2014 Nov; 11(11):3885-92. PubMed ID: 24717098
[TBL] [Abstract][Full Text] [Related]
15. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
16. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.
Maschauer S; Haubner R; Kuwert T; Prante O
Mol Pharm; 2014 Feb; 11(2):505-15. PubMed ID: 24325589
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
18. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
Lee YS; Jeong JM; Kim HW; Chang YS; Kim YJ; Hong MK; Rai GB; Chi DY; Kang WJ; Kang JH; Lee DS; Chung JK; Lee MC; Suh YG
Nucl Med Biol; 2006 Jul; 33(5):677-83. PubMed ID: 16843843
[TBL] [Abstract][Full Text] [Related]
19. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
